Template:Nicardipine: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Abdurahman Khalil (talk | contribs)
nocaptcha
3,981 edits
Created page with " {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F..."
 
Abdurahman Khalil (talk | contribs)
nocaptcha
3,981 edits
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 33: Line 33:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE I.V. how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE I.V. how supplied storage and handling|How Supplied/Storage and Handling]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE I.V. patient counseling information|Patient Counseling Information]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE I.V. labels and packaging|Labels and Packaging]]
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | CARDENE SR <sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | CARDENE SR <sup>®</sup> FDA Package Insert
Line 41: Line 41:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR dosage and administration|Dosage and Administration]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR dosage forms and strengths|Dosage Forms and Strengths]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR contraindications|Contraindications]]
Line 61: Line 59:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR nonclinical toxicology|Nonclinical Toxicology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR nonclinical toxicology|Nonclinical Toxicology]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR how supplied storage and handling|How Supplied/Storage and Handling]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR patient counseling information|Patient Counseling Information]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[CARDENE SR labels and packaging|Labels and Packaging]]
|-
|-
|}

Latest revision as of 15:57, 20 February 2014

Nicardipine
CARDENE I.V.® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packaging
CARDENE SR ® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packaging
Retrieved from "https://www.wikidoc.org/index.php?title=Template:Nicardipine&oldid=945634"